Prebiotic supplementation in full-term neonates: A systematic review of randomized controlled trials

Archives of Pediatrics and Adolescent Medicine

Volumn 163, Issue 8, 2009, Pages 755-764

  Rao, Shripada ^a,b,c   Srinivasjois, Ravisha ^a,b   Patole, Sanjay ^a,c  

^a KING EDWARD MEMORIAL HOSPITAL   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PREBIOTIC AGENT;

ABDOMINAL PAIN; ANTHROPOMETRY; ARTIFICIAL MILK; BACTERIAL COUNT; BIFIDOBACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECZEMA; FECES ANALYSIS; FECES CULTURE; FECES MICROFLORA; FLATULENCE; HUMAN; IRRITABILITY; LACTOBACILLUS; META ANALYSIS; NEWBORN; NEWBORN DISEASE; NEWBORN PERIOD; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REGURGITATION; REVIEW; SYSTEMATIC REVIEW; VOMITING; WEIGHT GAIN;

ANTHROPOMETRY; BIFIDOBACTERIUM; DIETARY SUPPLEMENTS; FECES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT FORMULA; INFANT, NEWBORN; LACTOBACILLUS; MALE; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 68149114497     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2009.94     Document Type: Review

References (53)

1. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet. 2003;361(9356): 512-519.
2. Neu J, Douglas-Escobar M, Lopez M. Microbes and the developing gastrointestinal tract. Nutr Clin Pract. 2007;22(2):174-182.
3. Lara-Villoslada F, Olivares M, Sierra S, Rodríguez JM, Boza J, Xaus J. Beneficial effects of probiotic bacteria isolated from breast milk. Br J Nutr. 2007;98(suppl 1):S96-S100. (Pubitemid 47543486)
4. Parracho H, McCartney AL, Gibson GR. Probiotics and prebiotics in infant nutrition. Proc Nutr Soc. 2007;66(3):405-411.
5. Coppa GV, Bruni S, Morelli L, Soldi S, Gabrielli O. The first prebiotics in humans: human milk oligosaccharides. J Clin Gastroenterol. 2004;38(6)(suppl):S80-S83.
6. Boehm G, Stahl B. Oligosaccharides from milk. J Nutr. 2007;137(3)(suppl 2): 847S-849S.
7. Harmsen HJ,Wildeboer-Veloo AC, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr. 2000;30(1):61-67.
8. Yoshioka H, Iseki K, Fujita K. Development and differences of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Pediatrics. 1983;72 (3):317-321.
9. Rubaltelli FF, Biadaioli R, Pecile P, Nicoletti P. Intestinal flora in breast- and bottlefed infants. J Perinat Med. 1998;26(3):186-191. (Pubitemid 28368013)
10. Eshach Adiv O, Berant M, Shamir R. New supplements to infant formulas. Pediatr Endocrinol Rev. 2004;2(2):216-224.
11. Roberfroid M. Prebiotics: the concept revisited. J Nutr. 2007;137(3)(suppl 2): 830S-837S.
12. Cummings JH, Macfarlane GT. Gastrointestinal effects of prebiotics. Br J Nutr. 2002;87(suppl 2):S145-S151.
13. Fanaro S, Boehm G, Garssen J, et al. Galacto-oligosaccharides and long-chain fructo-oligosaccharides as prebiotics in infant formulas: a review. Acta Paediatr Suppl. 2005;94(449):22-26. (Pubitemid 41512593)
14. Osborn DA, Sinn JK. Prebiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev. 2007;(4):CD006474.
15. Cochrane Neonatal Group. Resources for review authors. http://neonatal.cochrane .org/en/authors.html. Accessed December 6, 2007.
16. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999;354(9193):1896- 1900.
17. Centre for Reviews and Dissemination. CRD report 4: undertaking systematic reviews of research on effectiveness (2nd ed). http://www.york.ac.uk/ inst/crd /report4.htm. Published March 2001. Accessed January 10, 2007.
18. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1): 1-12. (Pubitemid 26120810)
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634. (Pubitemid 27387172)
20. Alliet P, Scholtens P, Raes M, et al. Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels. Nutrition. 2007;23(10):719-723. (Pubitemid 47422236)
21. Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable Bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Br J Nutr. 2005;94(5):783-790. (Pubitemid 41672384)
22. Bakker-Zierikzee AM, Tol EA, Kroes H, Alles MS, Kok FJ, Bindels JG. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Pediatr Allergy Immunol. 2006;17(2):134-140.
23. Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJ, Bindels JG. Prebiotic oligosaccharides in infant nutrition: addition of only galactooligosaccharides does not induce faecal acidic pH and SCFA-spectrum typical for breast fed infants [abstract PN1-20]. J Pediatr Gastroenterol Nutr. 2005;40(5):693.
24. Ben XM, Zhou XY, Zhao WH, et al. Supplementation of milk formula with galactooligosaccharides improves intestinal micro-flora and fermentation in term infants. Chin Med J (Engl). 2004;117(6):927-931.
25. Bettler J, Euler AR. An evaluation of the growth of term infants fed formula supplemented with fructo-oligosaccharide. Int J Probiotics Prebiotics. 2006;1(1): 19-26.
26. Costalos C, Kapiki A, Apostolou M, Papathoma E. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Early Hum Dev. 2008;84(1):45-49.
27. Decsi T, Arató A, Balogh M, et al. Randomised placebo controlled double blind study on the effect of prebiotic oligosaccharides on intestinal flora in healthy infants [in Hungarian]. Orv Hetil. 2005;146(48):2445-2450.
28. Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V. Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: effect on intestinal flora, stool characteristics, and pH. J Pediatr Gastroenterol Nutr. 2005; 41(2):186-190. (Pubitemid 41099366)
29. Moro G, Minoli I, Mosca M, et al. Dosage-related bifidogenic effects of galactoand fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002;34(3):291-295. (Pubitemid 34437523)
30. Moro GE, Mosca F, Miniello V, et al. Effects of a new mixture of prebiotics on faecal flora and stools in term infants. Acta Paediatr Suppl. 2003;91(441):77-79. (Pubitemid 37239256)
31. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch Dis Child. 2006;91(10):814-819. (Pubitemid 44521163)
32. Ziegler E, Vanderhoof JA, Petschow B, et al. Term infants fed formula supplemented with selected blends of prebioticsgrownormally and have soft stools similar to those reported for breast-fed infants. J Pediatr Gastroenterol Nutr. 2007;44(3):359-364. (Pubitemid 46673385)
33. Puccio G, Cajozzo C, Meli F, Rochat F, Grathwohl D, Steenhout P. Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics. Nutrition. 2007;23(1):1-8. (Pubitemid 44959766)
34. Haarman M, Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol. 2005;71(5):2318-2324. (Pubitemid 40646972)
35. Euler AR, Mitchell DK, Kline R, Pickering LK. Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk. J Pediatr Gastroenterol Nutr. 2005;40(2):157-164. (Pubitemid 40269735)
36. Savino F, Palumeri E, Castagno E, et al. Reduction of crying episodes owing to infantile colic: a randomized controlled study on the efficacy of a new infant formula. Eur J Clin Nutr. 2006;60(11):1304-1310. (Pubitemid 44669699)
37. Knol J, Scholtens P, Kafka C, et al. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: more like breast-fed infants. J Pediatr Gastroenterol Nutr. 2005;40(1):36-42. (Pubitemid 40180055)
38. Brunser O, Figueroa G, Gotteland M, et al. Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants. Asia Pac J Clin Nutr. 2006;15(3):368-376. (Pubitemid 44423418)
39. Kukkonen K, Savilahti E, Haahtela T, et al. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: a randomized, doubleblind, placebo-controlled trial. J Allergy Clin Immunol. 2007;119(1):192-198. (Pubitemid 46037805)
40. Schmelzle H, Wirth S, Skopnik H, et al. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high β-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr. 2003;36(3):343-351. (Pubitemid 39274606)
41. Scholtens PA, Alles MS, Willemsen LE, et al. Dietary fructo- oligosaccharides in healthy adults do not negatively affect faecal cytotoxicity: a randomised, doubleblind, placebo-controlled crossover trial. Br J Nutr. 2006;95(6):1143-1149.
42. Fuentes D, Fuentes LA, Lopez C, Suarez L, Escobar H. Clinical effect of a prebioticsupplemented formula in healthy infants during the first six months of life [abstract PG4-17]. J Pediatr Gastroenterol Nutr. 2005;40(5):660.
43. Boehm G, Lidestri M, Casetta P, et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2002;86(3):F178-F181. (Pubitemid 34478248)
44. Kapiki A, Costalos C, Oikonomidou C, Triantafyllidou A, Loukatou E, Pertrohilou V. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum Dev. 2007;83(5):335-339. (Pubitemid 46561170)
45. Mihatsch WA, Hoegel J, Pohlandt F. Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants. Acta Paediatr. 2006;95(7):843-848. (Pubitemid 44261744)
46. Veereman G. Pediatric applications of inulin and oligofructose. J Nutr. 2007;137 (11)(suppl):2585S-2589S.
47. Commission directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending directive 1999/21/EC. http://eur-lex.europa .eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:401:0001:0033:EN:PDF. Published December 30, 2006. Accessed November 8, 2007.
48. Cani PD, Dewever C, Delzenne NM. Inulin-type fructans modulate gastrointestinal peptides involved in appetite regulation (glucagons-like peptide-1 and ghrelin) in rats. Br J Nutr. 2004;92(3):521-526. (Pubitemid 40277074)
49. Cani PD, Joly E, Horsmans Y, Delzenne NM. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr. 2006;60(5):567-572. (Pubitemid 43922875)
50. Delzenne NM, Cani PD, Daubioul C, Neyrinck AM. Impact of inulin and oligofructose on gastrointestinal peptides. Br J Nutr. 2005;93(suppl 1):S157-S161. (Pubitemid 43073419)
51. Abrams SA, Griffin IJ, Hawthorne KM, Ellis KJ. Effect of prebiotic supplementation and calcium intake on body mass index. J Pediatr. 2007;151(3):293-298. (Pubitemid 47299100)
52. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J Nutr. 2008;138(6):1091-1095. (Pubitemid 351769134)
53. Corthésy B, Gaskins HR, Mercenier A. Cross-talk between probiotic bacteria and the host immune system. J Nutr. 2007;137(3)(suppl 2):781S-790S. (Pubitemid 46397518)